Barcelona, Spain-based Grifols announced that with Johnson & Johnson’s Ethicon, it received approval to market Vistaseal, a fibrin sealant to manage surgical bleeding. The sealant was developed by Grifols and combines two plasma proteins, fibrinogen and thrombin. The spray is administered with New Jersey-based Ethicon’s airless spray device.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,